| Literature DB >> 30639207 |
Andre Ma1, Stephanie W Y Yu1, Jasper K W Wong2.
Abstract
Glaucoma, a progressive optic neuropathy, is the leading cause of irreversible blindness worldwide. Glaucoma patients are usually initially managed with medications and laser therapies, before more invasive ocular surgeries. For laser treatments of glaucoma, laser trabeculoplasty and laser transscleral cyclophotocoagulation lower the intraocular pressure by increasing the aqueous outflow and decreasing the aqueous production, respectively. The development of a subthreshold laser technique, the micropulse laser, has been investigated as a potential alternative to traditional glaucoma laser procedures, with an aim to further decrease the risk of side effects without compromising the laser treatments' efficacy. Few reviews have been done on the 2 current micropulse laser treatments for glaucoma-micropulse laser trabeculoplasty and micropulse transscleral cyclophotocoagulation. Hence, the purpose of this review was to assess the efficacy and safety of micropulse laser techniques in the treatment of glaucoma.Entities:
Keywords: glaucoma; laser trabeculoplasty; micropulse laser; micropulse trabeculoplasty; micropulse transscleral cyclophotocoagulation; subthreshold laser
Year: 2019 PMID: 30639207 DOI: 10.1016/j.survophthal.2019.01.001
Source DB: PubMed Journal: Surv Ophthalmol ISSN: 0039-6257 Impact factor: 6.048